COV — CLEO Diagnostics Share News
0.000.00%
Last trade - 00:00- AU$67.06m
- AU$57.64m
- AU$1.18m
Brief: Cleo Diagnostics Seeks Trading Halt Pending Material Capital Raising Announcement
Brief: Cleo Diagnostics Says Partnership With Entityrisk
Australia's Cleo Diagnostics rises to near 2-month high on US approval for trial
Australia's Cleo Diagnostics jumps on US clinical trials for cancer blood test
Brief: Cleo Diagnostics Commences U.S. Regulatory Process With FDA
Australia's Cleo Diagnostics hits record high on positive study for cancer blood test
Cleo Diagnostics rises on appointing partner to start US market access program
Brief: Cleo Diagnostics Appoints Hcfocus To Support Commencement Of Its U.S. Market Access Program
Brief: Cleo Diagnostics Says Concluded Design Transfer Activities For Ovarian Cancer Detection Test
Brief: Cleo Diagnostics Seeks Trading Halt
Australia's Cleo Diagnostics hits near 2-week high on cancer program progress